RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PRINCIPE M
Collezione AOU Città della Salute di Torino

Items : 12

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience. in HemaSphere / Hemasphere. 2024 Jul 15;8(7):e128. doi: 10.1002/hem3.128. eCollection 2024 Jul.

2024
AOU Città della Salute di Torino

Bomben R; Zucchetto A; Laureana R; Chiarenza A; Olivieri J; Tissino E; Rossi FM; Vit F; Bittolo T; Papotti R; Pozzo F; Gaglio A; Degan M; Polesel J; Marasca R; Visentin A; Moia R; Innocenti I; Vitale C; Murru R; Varettoni M; Tafuri A; Zaja F; Postorino M; Martino EA; Condoluci A; Rossi D; Cuneo A; Di Raimondo F; et alii...

Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2023 Jun;61(6):106806. doi: 10.1016/j.ijantimicag.2023.106806. Epub 2023 Ap

2023
AOU Città della Salute di Torino

Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Bonuomo V; Busca A; Principe MID; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;

COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report. in Haematologica / Haematologica. 2022 Aug 1;107(8):1955-1959. doi: 10.3324/haematol.2021.280289.

2022
AOU Città della Salute di Torino

Chiaretti S; Bonifacio M; Agrippino R; Giglio F; Annunziata M; Curti A; Principe MID; Salutari P; Sciumè M; Delia M; Armenio M; Mancini V; Mulè A; Grimaldi F; Rege-Cambrin G; Santoro L; Lussana F; Chiusolo P; Pasciolla C; Scattolin AM; Cerrano M; Ciccone M; Defina M; Forghieri F; Mazzone C; Piccini M; Ferrara F; Pizzolo G; Foà R; et alii...

In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001071. doi: 10.1136/jitc-2020-001071.

2020
AOU Città della Salute di Torino

Mandili G; Curcio C; Bulfamante S; Follia L; Ferrero G; Mazza E; Principe M; Cordero F; Satolli MA; Spadi R; Evangelista A; Giordano D; Viet D; Cappello P; Novelli F;

Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study. in HemaSphere / Hemasphere. 2019 Nov 4;3(6):e320. doi: 10.1097/HS9.0000000000000320. eCollection 2019 Dec.

2019
AOU Città della Salute di Torino

Cattaneo C; Busca A; Gramegna D; Farina F; Candoni A; Piedimonte M; Fracchiolla N; Pagani C; Principe MID; Tisi MC; Offidani M; Fanci R; Ballanti S; Spolzino A; Criscuolo M; Marchesi F; Nadali G; Delia M; Picardi M; Sciumé M; Mancini V; Olivieri A; Tumbarello M; Rossi G; Pagano L;

FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis. in Oncogene / Oncogene. 2018 Feb 8;37(6):697-709. doi: 10.1038/onc.2017.358. Epub 2017 Oct 23.

2018
AOU Città della Salute di Torino

Scarpa A; Rusev B; Salvia R; Allavena P; Evangelista A; Curcio C; Santamorena MM; Roux C; Sassoe M; Principe M; Riganti C; Chattaragada MS; Cappello P; Novelli F;

Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. in Journal of hematology & oncology / J Hematol Oncol. 2017 Jan 13;10(1):16. doi: 10.1186/s13045-016-0385-8.

2017
AOU Città della Salute di Torino

Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F;

Alpha-Enolase (ENO1), a potential target in novel immunotherapies. in Frontiers in bioscience (Landmark edition) / Front Biosci (Landmark Ed). 2017 Jan 1;22(5):944-959. doi: 10.2741/4526.

2017
AOU Città della Salute di Torino

Cappello P; Principe M; Bulfamante S; Novelli F;

Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. in Oncotarget / Oncotarget. 2016 Feb 2;7(5):5598-612. doi: 10.18632/oncotarget.6798.

2016
AOU Città della Salute di Torino

Capello M; Ferri-Borgogno S; Riganti C; Chattaragada MS; Principe M; Roux C; Zhou W; Petricoin EF; Cappello P; Novelli F;

Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells. in Oncotarget / Oncotarget. 2015 May 10;6(13):11098-113. doi: 10.18632/oncotarget.3572.

2015
AOU Città della Salute di Torino

Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F;

Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. in Gastroenterology / Gastroenterology. 2013 May;144(5):1098-106. doi: 10.1053/j.gastro.2013.01.020. Epub 2013 Jan 16.

2013
AOU Città della Salute di Torino

Cappello P; Rolla S; Chiarle R; Principe M; Cavallo F; Perconti G; Feo S; Giovarelli M; Novelli F;

Three are better than one: plasminogen receptors as cancer theranostic targets. in Experimental hematology & oncology / Exp Hematol Oncol. 2013 Apr 17;2(1):12. doi: 10.1186/2162-3619-2-12.

2013
AOU Città della Salute di Torino

Ceruti P; Principe M; Capello M; Cappello P; Novelli F;